General Information
Version
.00
Revision date
2024-05-06
Product name
Maropitant Citrate Tablets 16, 24, 60 and 160 mg
1.2.1 Relevant identified uses
Maropitant Citrate tablets are indicated for the prevention of acute vomiting and the prevention of vomiting due to motion sickness in dogs
Emergency telephone
1-833-571-1525
Icons in SDS
Company Information
company name
of the Responsible Party
Section 2
SECTION 2: Hazards identification
Classification (GHS-US) Classification of the Substance or Mixture Classification (GHS-US) This product is a drug, as defined by the US Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.). It is in solid, final form for direct administration to the patient. Therefore, it is exempt from the US 2012 Hazard Communication Standard, as defined in the 29 CFR 1910.1200(b)(6)(vii)
2.2 Label elements
Physical hazard is not classified. However, it is serious hazards for eye damage/eye irritation, Specific target organ toxicity, Hazardous to the aquatic environment, Signal word is danger.
2.3 Other hazards
Causes serious eye damage. May cause damage to organs (cardiovascular system, liver) through prolonged or repeated exposure. Toxic to aquatic life with long lasting effects.
Ingredient(s) with unknown acute toxicity
Individuals with cardiac conditions may be more susceptible to toxicity in cases of overexposure.
2.1 Classification of the substance or mixture
Classification (GHS-US) This product is a drug, as defined by the US Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.). It is in solid, final form for direct administration to the patient. Therefore, it is exempt from the US 2012 Hazard Communication Standard, as defined in the 29 CFR 1910.1200(b)(6)(vii).